Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NSRX

Nasus Pharma Ltd

CIK 0002029039 · NYSE American

NYSE AmericanHealth CarePharmaceutical Preparations
$3.01
↓ 0.10 (-3.34%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$27.14M
P/E Ratio
-4.63
EPS
-0.72
Dividend Yield
Not covered
52W Position
13%
Beta
0.88

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
9.80
P/S
0.02
EV/Revenue
0.02
ROE
-211.6%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

227 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%
$1.98$9.99

Latest Financials

2025-12-31 FY
Revenue
$1.24B
Net Income
-$5.86M
Total Assets
$5.00M
Free Cash Flow
-$4.93M

Recent news